Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$221M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$166M |
| 3 |
Vulcan Materials
VMC
|
+$165M |
| 4 |
ANDV
Andeavor
ANDV
|
+$165M |
| 5 |
Apple
AAPL
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$251M |
| 2 |
Bank of America
BAC
|
+$225M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$214M |
| 4 |
K
Kellanova
K
|
+$188M |
| 5 |
Occidental Petroleum
OXY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 11.38% |
| 4 | Energy | 10.68% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Workiva
WK
$4.02B
| $628K | ﹤0.01% |
40,115
-122,325
| -75% | -$1.72M |
|
2677
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $627K | ﹤0.01% |
11,916
-20,044
| -63% | -$1.05M |
|
2678
Lineage Cell Therapeutics
LCTX
$281M
| $627K | ﹤0.01% |
+207,851
| New | +$590K |
|
2679
Greif Class B
GEF.B
$4.1B
| $626K | ﹤0.01% |
9,590
-472
| -5% | -$31.8K |
|
|
ARC
2680
DELISTED
ARC Document Solutions, Inc.
ARC
| $626K | ﹤0.01% |
181,418
+74,509
| +70% | +$335K |
|
2681
Cable One
CABO
$146M
| $624K | ﹤0.01% |
1,000
-16,973
| -94% | -$10.6M |
|
2682
Great Southern Bancorp
GSBC
$853M
| $624K | ﹤0.01% |
12,348
-6,415
| -34% | -$326K |
|
|
CLCT
2683
DELISTED
Collectors Universe
CLCT
| $624K | ﹤0.01% |
+23,924
| New | +$548K |
|
|
RPXC
2684
DELISTED
RPX Corporation
RPXC
| $621K | ﹤0.01% |
51,710
-109,475
| -68% | -$1.24M |
|
|
PDT
2685
John Hancock Premium Dividend Fund
PDT
$622M
| $620K | ﹤0.01% |
+38,998
| New | +$615K |
|
|
TTOO
2686
DELISTED
T2 Biosystems, Inc
TTOO
| $620K | ﹤0.01% |
24
-3
| -11% | -$84.4K |
|
|
PZE
2687
DELISTED
Petrobras Argentina S A
PZE
| $619K | ﹤0.01% |
56,003
-8,337
| -13% | -$78.1K |
|
2688
HSBC
HSBC
$356B
| $617K | ﹤0.01% |
16,741
-209,032
| -93% | -$7.85M |
|
2689
ResMed
RMD
$34.1B
| $617K | ﹤0.01% |
8,569
+4,959
| +137% | +$343K |
|
|
JUNO
2690
DELISTED
Juno Therapeutics, Inc.
JUNO
| $617K | ﹤0.01% |
+27,827
| New | +$597K |
|
2691
Lee Enterprises
LEE
$185M
| $616K | ﹤0.01% |
23,698
+19,613
| +480% | +$558K |
|
2692
MGE Energy Inc
MGEE
$2.99B
| $616K | ﹤0.01% |
9,477
+5,035
| +113% | +$318K |
|
|
EPE
2693
DELISTED
EP Energy Corporation
EPE
| $616K | ﹤0.01% |
129,644
+114,066
| +732% | +$584K |
|
2694
Northwest Natural Holdings
NWN
$2.11B
| $615K | ﹤0.01% |
10,401
+6,167
| +146% | +$364K |
|
2695
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.7B
| $615K | ﹤0.01% |
11,705
-11,492
| -50% | -$602K |
|
|
IRS
2696
IRSA Inversiones y Representaciones
IRS
$1.27B
| $614K | ﹤0.01% |
+26,027
| New | +$556K |
|
|
PMT
2697
PennyMac Mortgage Investment
PMT
$809M
| $614K | ﹤0.01% |
34,617
-123,878
| -78% | -$2.1M |
|
2698
Minerva Neurosciences
NERV
$256M
| $613K | ﹤0.01% |
9,458
-57,554
| -86% | -$4.47M |
|
|
PPP
2699
DELISTED
Primero Mining Corp
PPP
| $613K | ﹤0.01% |
1,113,901
-629,447
| -36% | -$443K |
|
2700
Minerals Technologies
MTX
$2.25B
| $612K | ﹤0.01% |
+7,988
| New | +$619K |
|
Similar funds
Israel Englander's Q1 2017 Portfolio in Review
As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Israel Englander deployed $4.44B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.
- Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
- Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
- Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
- Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
- Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
- Israel Englander opened 894 new positions and closed 743 in Q1 2017.
- Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.